5 completed, 2 unknown. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Unknown 2 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Inhaled Levosimendan Levosimendan 2.5 milligram/milliliter Injectable Solutiondose Inhaled, Levosimendan 2.5 milligram/milliliter Injectable Solutiondose Intravenous - Left Ventricular Dysfunction | Phase 2 | Unknown | Universitair Ziekenhuis Brussel | 6 | 2024-02-01 | 2024-05-20 |
| Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery bone marrow mononuclear cells injection, placebo intramyocardial injection - Old Myocardial Infarction, Chronic Myocardial Ischemia | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 60 | 2010-12-01 | 2011-01-12 |
| Mesenchymal Stem Cells and Myocardial Ischemia Mesenchymal stem cells - Chronic Myocardial Ischemia, Left Ventricular Dysfunction | Phase 1 / Phase 2 | Completed | University Hospital, Toulouse | 10 | 2009-10-01 | 2014-09-19 |
| Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study) Adult stem cells, Placebo - Chronic Ischemic Heart Disease, Left Ventricular Dysfunction | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 92 | 2009-03-01 | 2015-07-01 |
| Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) Adult stem cells, Placebo - Left Ventricular Dysfunction | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 87 | 2008-07-01 | 2015-07-10 |
| Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study) Adult stem cells, Placebo - Left Ventricular Dysfunction | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 120 | 2008-07-01 | 2015-06-30 |
| RESTOR-MV: Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve Less invasive mitral valve repair - Mitral Valve Regurgitation, Left Ventricular Dysfunction | Phase 2 | Completed | Myocor | 250 | 2004-06-01 | 2009-05-07 |
Ventricular Dysfunction, Left (7) · Heart Failure (2) · Angina Pectoris (1) · Coronary Artery Disease (1) · Mitral Valve Insufficiency (1) · Respiratory Aspiration (1)
Cardiovascular Diseases (7) · Heart Diseases (7) · Ventricular Dysfunction (7) · Myocardial Ischemia (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Chest Pain (1) · Coronary Disease (1) · Heart Valve Diseases (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Respiration Disorders (1)
The University of Texas Health Science Center, Houston (3) · Chinese PLA General Hospital (1) · Myocor (1) · Universitair Ziekenhuis Brussel (1) · University Hospital, Toulouse (1)
United States (4) · Belgium (1) · China (1) · France (1)
Robert Simari, MD (3) · Gao Changqing, MD (1) · Matthias Raes, MD (1)
PMID 25136078, PMID 20844613, PMID 21126639, PMID 21168015, PMID 22084195, PMID 22447880, PMID 23129008, PMID 24247415, PMID 25406300, PMID 26901787, PMID 27595689, PMID 28490433, PMID 29208679
U01HL087318 (3)